Tornier NV  

(Public, NASDAQ:TRNX)   Watch this stock  
Find more results for TRNX
-0.47 (-1.86%)
May 5 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 24.57 - 25.66
52 week 17.51 - 28.53
Open 25.25
Vol / Avg. 87,882.00/131,694.00
Mkt cap 1.23B
P/E     -
Div/yield     -
EPS -0.60
Shares 48.99M
Beta 1.25
Inst. own 91%
Jun 18, 2015
Tornier NV Annual Shareholders Meeting - 3:00AM EDT - Add to calendar
May 5, 2015
Q1 2015 Tornier NV Earnings Call - 4:30PM EDT - Add to calendar
May 5, 2015
Q1 2015 Tornier NV Earnings Release
Feb 24, 2015
Q4 2014 Tornier NV Earnings Call
Feb 24, 2015
Q4 2014 Tornier NV Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -9.16% -8.54%
Operating margin -4.34% -6.21%
EBITD margin - 6.86%
Return on average assets -5.13% -4.32%
Return on average equity -7.00% -5.87%
Employees 1,121 -
CDP Score - -


Prins Bernhardplein 200
+31-20-6754002 (Phone)
+31-10-4718888 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Tornier N.V. (Tornier) is a global medical device company focused on surgeons that treat musculoskeletal injuries and disorders of the shoulder, elbow, wrist, hand, ankle and foot. The Company sells a broad line of joint replacement, trauma, sports medicine and biologic products to treat extremity joints. The products are focused on Upper extremity joints and trauma, Lower extremity joints and trauma, Sports medicine and biologics, and Large joints and other. Its trademarks are Aequalis, Aequalis Ascend, Aequalis Ascend Flex, Aequalis Fracture, Aequalis IM Nail, Aequalis Primary, Aequalis Reversed Fracture, Aequalis Reversed II, ArthroTunneler, BioFiber, Cannulink, Conexa, Force Fiber, Insite, Insite FT, Latitude, Latitude EV, MaxLock, MaxLock Extreme, MiniMaxLock, Phantom Fiber, Piton, PYC Humeral Head, Salto, Salto Total Ankle, Salto Talaris, Simpliciti and Tornier.

Officers and directors

David H. Mowry President, Chief Executive Officer, Executive Director
Age: 51
Bio & Compensation  - Reuters
Shawn T. McCormick Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
Kevin M. Klemz Senior Vice President, chief legal officer, Secretary
Age: 53
Bio & Compensation  - Reuters
Stephan Epinette Senior Vice President-international commercial operations
Age: 43
Bio & Compensation  - Reuters
Gregory Morrison Senior Vice President-Global Human resources
Age: 50
Bio & Compensation  - Reuters
Terry M. Rich Senior Vice President - U.S. Commercial Operations
Age: 45
Bio & Compensation  - Reuters
Gordon W. Van Ummersen Senior Vice President of Global Product Delivery
Age: 53
Bio & Compensation  - Reuters
Sean D. Carney Non-Executive Independent Chairman of the Board
Age: 46
Bio & Compensation  - Reuters
Kevin C. O'Boyle CPA Interim Non-Executive Independent Vice Chairman of the Board
Age: 59
Bio & Compensation  - Reuters
Alain Tornier Non-Executive Director
Age: 68
Bio & Compensation  - Reuters